Healthcare provider profile · identity verified

Bernd Raphael, MD

Allopathic & Osteopathic Physicians|Internal Medicine · LEHIGH ACRES, FL · NPI 1255306213

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Bernd Raphael, MD received $72.64 in general payments during 2025 across 1 reported records.

SPINEFRONTIER, INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$72.64

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
SPINEFRONTIER, INC.	Unresolved — no canonical attribution shown	$72.64	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$72.64	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FacetFUSE Normalized: facetfuse	Device	SPINEFRONTIER, INC.	$72.64	1	2025
Source payment records 2025-01-07 · SPINEFRONTIER, INC. · $72.64 · Open Payments source
Inspan Normalized: inspan	Device	SPINEFRONTIER, INC.	$72.64	1	2025
Source payment records 2025-01-07 · SPINEFRONTIER, INC. · $72.64 · Open Payments source
NanoFUSE Normalized: nanofuse	Device	SPINEFRONTIER, INC.	$72.64	1	2025
Source payment records 2025-01-07 · SPINEFRONTIER, INC. · $72.64 · Open Payments source
SIJFuse Normalized: sijfuse	Device	SPINEFRONTIER, INC.	$72.64	1	2025
Source payment records 2025-01-07 · SPINEFRONTIER, INC. · $72.64 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	794	253
Amlodipine Besylate	Amlodipine Besylate	724	236
Levothyroxine Sodium	Levothyroxine Sodium	586	181
Azithromycin	Azithromycin	549	342
Metformin Hcl	Metformin Hcl	524	178
Losartan Potassium	Losartan Potassium	501	158
Lisinopril	Lisinopril	458	150
Omeprazole	Omeprazole	383	129
Temazepam	Temazepam	376	111
Gabapentin	Gabapentin	337	130
Albuterol Sulfate Hfa	Albuterol Sulfate	331	121
Tamsulosin Hcl	Tamsulosin Hcl	273	94
Tramadol Hcl	Tramadol Hcl	251	92
Furosemide	Furosemide	246	92
Metoprolol Tartrate	Metoprolol Tartrate	243	83
Glipizide	Glipizide	230	76
Pantoprazole Sodium	Pantoprazole Sodium	223	74
Simvastatin	Simvastatin	215	72
Prednisone	Prednisone	211	89
Metoprolol Succinate	Metoprolol Succinate	210	79
Potassium Chloride	Potassium Chloride	205	65
Hydrochlorothiazide	Hydrochlorothiazide	204	74
Alprazolam	Alprazolam	201	75
Baclofen	Baclofen	187	70
Pioglitazone Hcl	Pioglitazone Hcl	184	58
Montelukast Sodium	Montelukast Sodium	178	51
Clopidogrel	Clopidogrel Bisulfate	167	61
Rosuvastatin Calcium	Rosuvastatin Calcium	165	59
Zolpidem Tartrate	Zolpidem Tartrate	159	63
Ibuprofen	Ibuprofen	151	69
Sertraline Hcl	Sertraline Hcl	147	47
Ozempic	Semaglutide	142	39
Methylprednisolone	Methylprednisolone	139	114
Meclizine Hcl	Meclizine Hcl	138	54
Trazodone Hcl	Trazodone Hcl	136	45
Atenolol	Atenolol	130	34
Carvedilol	Carvedilol	130	43
Famotidine	Famotidine	122	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	59
Alendronate Sodium	Alendronate Sodium	110	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	106	32
Pregabalin	Pregabalin	100	32
Triamcinolone Acetonide	Triamcinolone Acetonide	99	46
Ciprofloxacin Hcl	Ciprofloxacin Hcl	98	66
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	98	29
Meloxicam	Meloxicam	98	36
Torsemide	Torsemide	98	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	96	30
Ezetimibe	Ezetimibe	91	28
Fluticasone Propionate	Fluticasone Propionate	86	26
Lovastatin	Lovastatin	86	28
Paroxetine Hcl	Paroxetine Hcl	86	29
Escitalopram Oxalate	Escitalopram Oxalate	84	21
Levofloxacin	Levofloxacin	84	67
Fluoxetine Hcl	Fluoxetine Hcl	83	32
Allopurinol	Allopurinol	82	28
Ibu	Ibuprofen	81	17
Oxybutynin Chloride	Oxybutynin Chloride	78	23
Citalopram Hbr	Citalopram Hydrobromide	77	26
Eliquis	Apixaban	77	37
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	73	40
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	73	52
Clonidine Hcl	Clonidine Hcl	71	23
Hydralazine Hcl	Hydralazine Hcl	71	21
Dropsafe Prep Pads	Alcohol Antiseptic Pads	69	21
Cephalexin	Cephalexin	67	50
Spironolactone	Spironolactone	67	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	25
Doxycycline Monohydrate	Doxycycline Monohydrate	64	48
Lorazepam	Lorazepam	64	26
Celecoxib	Celecoxib	63	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	16
Ondansetron Hcl	Ondansetron Hcl	62	28
Duloxetine Hcl	Duloxetine Hcl	58	26
Finasteride	Finasteride	58	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	19
Pravastatin Sodium	Pravastatin Sodium	55	19
Testosterone Cypionate	Testosterone Cypionate	53	21
Propranolol Hcl	Propranolol Hcl	52	15
Benazepril Hcl	Benazepril Hcl	50	16
Synthroid	Levothyroxine Sodium	50	12
Amoxicillin	Amoxicillin	48	34
Diclofenac Sodium	Diclofenac Sodium	47	22
Donepezil Hcl	Donepezil Hcl	43	17
Bupropion Hcl Sr	Bupropion Hcl	42	20
Clonazepam	Clonazepam	42	15
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	41	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	11
Terbinafine Hcl	Terbinafine Hcl	40	24
Valacyclovir	Valacyclovir Hcl	39	23
Xarelto	Rivaroxaban	39	14
Glipizide Er	Glipizide	38	12
Diazepam	Diazepam	37	14
Droplet Pen Needle	Pen Needle, Diabetic	37	suppressed
Glimepiride	Glimepiride	37	13
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	35	suppressed
Terazosin Hcl	Terazosin Hcl	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	14
Warfarin Sodium	Warfarin Sodium	34	12
Amitriptyline Hcl	Amitriptyline Hcl	33	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	12
Sildenafil Citrate	Sildenafil Citrate	32	15
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	31	29
Levetiracetam	Levetiracetam	30	13
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Enalapril Maleate	Enalapril Maleate	29	11
Memantine Hcl	Memantine Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	28	25
Fenofibrate	Fenofibrate	27	suppressed
Fluconazole	Fluconazole	26	21
Jantoven	Warfarin Sodium	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	11
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Methotrexate	Methotrexate Sodium	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	15
Nifedipine Er	Nifedipine	24	suppressed
Sucralfate	Sucralfate	22	12
Valsartan	Valsartan	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Nitroglycerin	Nitroglycerin	21	16
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Ramipril	Ramipril	19	suppressed
Topiramate	Topiramate	19	suppressed
Acyclovir	Acyclovir	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Droplet Insulin Syringe	Syringe And Needle,insulin,1ml	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Amiloride Hcl	Amiloride Hcl	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Megestrol Acetate	Megestrol Acetate	15	suppressed
Nystatin	Nystatin	15	suppressed
Droplet Insulin Syringe	Syrge-Ndl,ins 0.5 Ml Half Mark	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Primidone	Primidone	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	13	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Naproxen	Naproxen	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Colchicine	Colchicine	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Indomethacin	Indomethacin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Risperidone	Risperidone	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$72.64 · 1 records	SPINEFRONTIER, INC.	FacetFUSE, Inspan, NanoFUSE, SIJFuse	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error